Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Weekly News Recap #Phispers
US Medicaid
NA
Finished Drug Prices
NA
1. Akb-6548
1. 1000025-07-9
2. Akb-6548
3. Pg-1016548
4. Vadadustat [usan]
5. N-(5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl)glycine
6. B506
7. Pg1016548
8. B-506
9. Akb6548
10. (5-(3-chlorophenyl)-3-hydroxypicolinoyl)glycine
11. I60w9520vv
12. 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic Acid
13. Glycine, N-((5-(3-chlorophenyl)-3-hydroxy-2-pyridinyl)carbonyl)-
14. Glycine, N-[[5-(3-chlorophenyl)-3-hydroxy-2-pyridinyl]carbonyl]-
15. Vafseo
16. Glycine, N-[[5-(3-chlorophenyl)-3-hydroxy-2-pyridinyl]carbonyl]-;glycine, N-[[5-(3-chlorophenyl)-3-hydroxy-2-pyridinyl]carbonyl]-
17. Unii-i60w9520vv
18. Us8722895, 11: {[5-(3-chlorophenyl)-3-hydroxypyridine-2- Carbonyl]amino}-acetic Acid
19. A1z
20. Vafseo (tn)
21. Vadadustat [inn]
22. Vadadustat [jan]
23. Us8722895, 10: {[5-(3-chlorophenyl)-3-hydroxypyridine-2- Carbonyl]amino}-acetic Acid Trifluoroacetic Acid Salt
24. Vadadustat [who-dd]
25. Vadadustat (jan/usan/inn)
26. Schembl1920738
27. Chembl3646221
28. Gtpl11831
29. Bdbm107704
30. Dtxsid501179936
31. Amy27885
32. Bcp19497
33. Ex-a2573
34. 2-{[5-(3-chlorophenyl)-3-hydroxypyridin-2-yl]formamido}acetic Acid
35. Gsk128863
36. S6490
37. Zinc117532869
38. Cs-6373
39. Db12255
40. Sb19204
41. Us8598210, Table Xv, 10
42. Us8598210, Table Xv, 11
43. Ac-30928
44. As-71695
45. Db-102455
46. Hy-101277
47. Vadadustat; Pg-1016548; Akb-6548
48. J3.560.572j
49. C71001
50. D11078
51. Us8598210, 119
52. Q27280485
53. 2-(5-(3-chlorophenyl)-3-hydroxypicolinamido)acetic Acid
54. Akb-6548; B-506; Pg-1016548
55. {[5-(3-chlorophenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic Acid
56. {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic Acid
Molecular Weight | 306.70 g/mol |
---|---|
Molecular Formula | C14H11ClN2O4 |
XLogP3 | 2.5 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 4 |
Exact Mass | 306.0407345 g/mol |
Monoisotopic Mass | 306.0407345 g/mol |
Topological Polar Surface Area | 99.5 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 393 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Treatment of anaemia due to chronic disorders
B - Blood and blood forming organs
B03 - Antianemic preparations
B03X - Other antianemic preparations
B03XA - Other antianemic preparations
B03XA08 - Vadadustat
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?